Sitemap

Institute Expand / Hide

• Contact persons

• Organizational structure

• Institute directors

• Quality assurance

• Our network Expand / Hide

  • Animal research at Fraunhofer ITEM Expand / Hide

    • Contact form

• Institute chronicles

• Board of trustees

• Mission statement

R&D expertise Expand / Hide

• Cardiopulmonary research Expand / Hide

  • Neutrophil subset

  • Ambrosia pollen

  • Investigation of neoepitope biomarkers

  • Exhaled Particles

  • Inhaled booster Vaccination against Corona

• Toxicology Expand / Hide

  • Replacing animal testing

  • Assesing microplastic inhalation Toxicity

  • Nitrosamines

  • Determination and prediction of inhalation and dermal exposure from foam spray applications

  • Niobium

  • DZSF project

  • ZeroPM

  • Project MONO4ERA

  • NanoINHAL

  • Project SEAWave

  • Toxicological risk assessment for PFAS

• Immunology and infection research Expand / Hide

  • Coronavirus research

  • iGUARD

  • Cyclosporin A

  • Designer immune cells

• Malignant disease research Expand / Hide

  • Single-cell sequencing

  • Brain tumor diagnosis with liquid biopsy

  • Acess to personalized oncology

• Medical and Pharmaceutical Engineering Expand / Hide

  • Innovation for preterm neonates

  • Personalized finger joint implants based on AI

  • REMEDIA project

• Bioinformatics and AI Expand / Hide

  • BIOSYNTH project

  • Project MyDeepLearn

  • Project »Genealyzer«

  • project ELISE

• RNA technologies Expand / Hide

  • CIMD-Cluster

• Project archive

Services Expand / Hide

• Drug Development Expand / Hide

  • GMP manufacturing of biopharmaceuticals for clinical trials

  • Regulatory research and risk assessment in drug development Expand / Hide

    • Environmental risk assessment (ERA)

  • Preclinical research and testing Expand / Hide

    • Efficacy

    • Toxicology testing

  • Clinical trials

  • #WeKnowClinicalResearch

• Chemical safety and assessment Expand / Hide

  • Bio- and Environmental Analytics Expand / Hide

    • Organophosphorus compounds

  • Toxicology testing

  • Exposure characterization

  • Regulatory risk assessment

  • Regulatory research Expand / Hide

    • ZET-O-MAP

• Translational Biomedical Engineering Expand / Hide

  • Device development and manufacturing processes

  • Testing and test methods

  • Regulatory support

• Bioinformatics Expand / Hide

  • Form landing customized training courses

• Personalized Tumor Therapy Expand / Hide

  • Method Development Expand / Hide

    • Preclinical Models

    • Multiomics and single-cell analysis

    • Bioinformatic and mathematical modelling

    • Preanalytics & diagnostics

  • Preclinical application

  • Clinical translation

CRC Hannover

Events Expand / Hide

• 23rd DGRA Annual Congress

• ERS International Congress 2021

• 5th ACTC 2021: Advances in Circulating Tumor Cells

• BioEM – The Joint Annual Meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association

• Oral presentation at New and Emerging Technologies 2021

• DGK Herztage

• Congress of the European Society of Gene and Cell Therapy

• 2nd International Akademie Fresenius Conference

• Models of Lung Disease 2022 - Save the date

• Oral presentation within the LifeScienceNet Düsseldorf webinar

• Oral presentation at OECT Summit 2022

• 7th German Pharm-Tox Summit

• SOT Annual Meeting and ToxExpo 2022 in San Diego

• Regulatory Forum

• 3R in cardiovascular research

• Fraunhofer CIMD Summer School 2022

• AACR 2022

• Development of predictive human stem cell-based models in neurotoxicology and -infectiology

• ATS 2022

• CIMD session 3: NGRA

• ENDS Europe 2022

• ONE – Health, Environment, Society – Conference 2022

• LIVe2022

• EACR 2022 annual congress

• CIMD session 4: In vitro tissue models

• CIMD session 5: Multiplex immunohistology

• 10th IWPFI – Lung Imaging Together in Hannover

• EUSAAT congress

• CIMD session 6: Human immunocompetent lung model for infection studies

• CIMD session 7: In silico methods in regulatory toxicology – skin sensitization as an example

• Models of Lung Disease 2023 - Save the date

• Workshop "Alternatives to Animal Testing" 2023 - Save the date

• SOT Annual Meeting and ToxExpo 2023 in Nashville

• 8th German Pharm-Tox Summit

• Models of Lung Disease 2023 Expand / Hide

  • Program

• ATS 2023

• KSOT 2023

• ENDS 2023

• Inhaled Particles and NanOEH Conference 2023

• Alternatives to Animal Testing 2023 Expand / Hide

  • Program

• ISAM 2023

• EuroTox 2023

• ERS 2023

• Models of Lung Disease 2024

• IUIS 2023

Press and media Expand / Hide

• Newsletter

• Annual reports

• Publications

• Press releases Expand / Hide

  • SILIFE

  • Reviewing OECD Test Guidelines

  • Rhinovirus-induced human lung tissue responses mimic COPD and asthma gene signatures

  • ZeroPM: Zero pollution from persistent, mobile substances

  • AVATOR - Tracking down aerosols

  • AVATOR - Indoor Air: How to Eliminate Viruses Effectively

  • ATMPs – long way to clinical application, but high therapeutic added value

  • Institute director Prof. Thomas Thum is one of the most cited researchers worldwide

  • Understanding heart failure and developing innovative therapies

  • Rapid therapeutic approaches for viral diseases

  • Machine learning in pediatric intensive-care medicine

  • REMEDIA project

  • Project MONO4ERA

  • Alternative to animal models: Advances in medicine through human-relevant disease models

  • Better models to shed light on the mutagenicity of N-nitrosamines

  • COVID-19 Research Network Lower Saxony: Pooling expertise to fight SARS-CoV-2

  • RNA therapy for heart failure and organ fibrosis

  • Inhaling microplastics – how dangerous is that?

  • Clinical trial MVA: Researchers want to test the efficacy of an inhaled vaccine

  • Checking the immune response in the lungs

  • Natural product-based compound screening identifies highly efficient anti-fibrotic substances

  • Fraunhofer heading for future predictive models

  • Prof. Ulrich Mohr passed away

  • On the home stretch to the RNA drug against cardiac fibrosis

  • Automated production technologies for mRNA-based drugs

  • Fraunhofer project FibroPaths®: enabling rapid and safe development of antifibrotic drugs

  • Novel immune cell platforms for health research – start of Fraunhofer Attract group in Hannover

  • Multi-organ chip detects dangerous nanoparticles

  • Project Biosynth

  • 1.5 million euros for rapid therapies against viral diseases

  • High Performance Center at COMPAMED 2022

  • Designer immune cells for drug discovery, potency and safety testing

  • Bioresorbable membrane for healing internal and external wounds

  • Final Report: Review of the OECD Test Guidelines

  • Environmental risk assessment (ERA)

  • 2.5 million euros for rapid therapies against viral diseases

• News

• Thematic Flyers

Career Expand / Hide

• Direct entry

• Students

Contact